These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 27109788)
1. Relapse in schizophrenia: Definitively not a bolt from the blue. Spaniel F; Bakstein E; Anyz J; Hlinka J; Sieger T; Hrdlicka J; Görnerová N; Höschl C Neurosci Lett; 2018 Mar; 669():68-74. PubMed ID: 27109788 [TBL] [Abstract][Full Text] [Related]
2. Systematic review of early warning signs of relapse and behavioural antecedents of symptom worsening in people living with schizophrenia spectrum disorders. Gleeson JF; McGuckian TB; Fernandez DK; Fraser MI; Pepe A; Taskis R; Alvarez-Jimenez M; Farhall JF; Gumley A Clin Psychol Rev; 2024 Feb; 107():102357. PubMed ID: 38065010 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of information technology assisted relapse prevention program on relapse among people who live with severe mental disorders. Ehsani M; Maarefvand M; Hosseinzadeh S; Zabihi Poursaadati M Int J Soc Psychiatry; 2024 May; 70(3):531-541. PubMed ID: 38166425 [TBL] [Abstract][Full Text] [Related]
4. The Cost of Relapse in Schizophrenia. Pennington M; McCrone P Pharmacoeconomics; 2017 Sep; 35(9):921-936. PubMed ID: 28534254 [TBL] [Abstract][Full Text] [Related]
5. Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence. Lecomte T; Potvin S; Samson C; Francoeur A; Hache-Labelle C; Gagné S; Boucher J; Bouchard M; Mueser KT J Abnorm Psychol; 2019 Nov; 128(8):840-854. PubMed ID: 31343181 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Camacho-Gomez M; Castellvi P Schizophr Bull; 2020 Jan; 46(1):98-109. PubMed ID: 31050757 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and Impact of Relapse in Patients With Schizophrenia. Lauriello J J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32237296 [TBL] [Abstract][Full Text] [Related]
9. Current Concepts and Treatments of Schizophrenia. Stępnicki P; Kondej M; Kaczor AA Molecules; 2018 Aug; 23(8):. PubMed ID: 30127324 [TBL] [Abstract][Full Text] [Related]
10. Psychiatric consequences and issues of long COVID on patients with prior psychiatric comorbidities: a scoping review. Hovagemyan F; Dugerdil A; Braggion A; Mallet L; Flahault A Front Psychiatry; 2023; 14():1181767. PubMed ID: 37351002 [TBL] [Abstract][Full Text] [Related]
11. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT. Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Birchwood M; Briggs A; Bucci S; Cotton S; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung A; Aucott L; Farhall J; Gleeson J Health Technol Assess; 2022 May; 26(27):1-174. PubMed ID: 35639493 [TBL] [Abstract][Full Text] [Related]
12. Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain. Gutiérrez-Rojas L; Sánchez-Alonso S; García Dorado M; López Rengel PM CNS Drugs; 2022 May; 36(5):517-527. PubMed ID: 35460508 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the utility of digital phenotyping to predict health outcomes in schizophrenia: protocol for the HOPE-S observational study. Abdul Rashid NA; Martanto W; Yang Z; Wang X; Heaukulani C; Vouk N; Buddhika T; Wei Y; Verma S; Tang C; Morris RJT; Lee J BMJ Open; 2021 Oct; 11(10):e046552. PubMed ID: 34670760 [TBL] [Abstract][Full Text] [Related]
14. mHealth-Assisted Detection of Precursors to Relapse in Schizophrenia. Buck B; Hallgren KA; Campbell AT; Choudhury T; Kane JM; Ben-Zeev D Front Psychiatry; 2021; 12():642200. PubMed ID: 34135781 [TBL] [Abstract][Full Text] [Related]
15. Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support. Gumley A; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Beattie L; Bell I; Birchwood M; Briggs A; Bucci S; Castagnini E; Clark A; Cotton SM; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; Matrunola C; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Smith L; Sundram S; Thomson D; Thompson A; Whitehill H; Wilson-Kay A; Williams C; Yung A; Farhall J; Gleeson J JMIR Res Protoc; 2020 Jan; 9(1):e15058. PubMed ID: 31917372 [TBL] [Abstract][Full Text] [Related]
16. Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook. Birnbaum ML; Ernala SK; Rizvi AF; Arenare E; R Van Meter A; De Choudhury M; Kane JM NPJ Schizophr; 2019 Oct; 5(1):17. PubMed ID: 31591400 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report. Eisner E; Bucci S; Berry N; Emsley R; Barrowclough C; Drake RJ Schizophr Res; 2019 Jun; 208():105-113. PubMed ID: 30979665 [TBL] [Abstract][Full Text] [Related]
18. A comparison of passive and active estimates of sleep in a cohort with schizophrenia. Staples P; Torous J; Barnett I; Carlson K; Sandoval L; Keshavan M; Onnela JP NPJ Schizophr; 2017 Oct; 3(1):37. PubMed ID: 29038553 [TBL] [Abstract][Full Text] [Related]
19. CrossCheck: Integrating self-report, behavioral sensing, and smartphone use to identify digital indicators of psychotic relapse. Ben-Zeev D; Brian R; Wang R; Wang W; Campbell AT; Aung MSH; Merrill M; Tseng VWS; Choudhury T; Hauser M; Kane JM; Scherer EA Psychiatr Rehabil J; 2017 Sep; 40(3):266-275. PubMed ID: 28368138 [TBL] [Abstract][Full Text] [Related]